RxDoctor Payments Data

Smita Reddy

Psychiatry · Sacramento, CANPI 1184887507

Payments from drug & device makers

$7,856in general payments, 2019–2025

Across 72 payments — averaging $109.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$7K
  • Johnson & Johnson$294
  • Tris Pharma Inc$219
  • Takeda Pharmaceuticals U.S.A., Inc.$109
  • Neurocrine Biosciences, Inc.$108
  • Sage Therapeutics, LLC$104
  • plus $309 from 8 others

What the payments were for

  • Food & beverage$1,57698%
  • Education$302%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,856 in reported general payments places this provider in the 90th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Medicare billing

Part B allowed, 2024
$15,212
Medicare patients
19
Services billed
134

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole18$25,507
Invega SustennaPaliperidone Palmitate12$25,470
VraylarCariprazine Hcl12$16,477
Duloxetine Hcl85$2,584
Atomoxetine Hcl12$2,416
Quetiapine Fumarate97$1,471
Vilazodone Hcl18$1,160
Lamotrigine60$1,124
Olanzapine38$946
Ziprasidone Hcl24$934
Venlafaxine Hcl ErVenlafaxine Hcl71$926
Aripiprazole40$831
Bupropion XlBupropion Hcl57$746
Clonazepam53$681
Methylphenidate Hcl15$669

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$75$25,50718 claims
Johnson & JohnsonInvega Sustenna$294$25,47012 claims
AbbVieVraylar$6,712$16,47712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,954 psychiatry providers in California.

Other psychiatry in Sacramento

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →